TaiGen Biopharmaceuticals Holdings Ltd

NEW
ROCO:4157 (Taiwan)  
NT$ 8.88 (0%) Sep 22
43.14
P/B:
6.30
Market Cap:
NT$ 6.45B ($ 203.69M)
Enterprise V:
NT$ 5.55B ($ 175.15M)
Volume:
696.97K
Avg Vol (2M):
789.04K
Trade In:
Volume:
696.97K
Avg Vol (2M):
789.04K

TaiGen Biopharmaceuticals Holdings Ltd (ROCO:4157) Dividend

TaiGen Biopharmaceuticals Holdings Ltd (ROCO:4157) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of 0.2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ROCO:4157 Dividend

Does TaiGen Biopharmaceuticals Holdings Ltd (ROCO:4157) pay a dividend?

TaiGen Biopharmaceuticals Holdings Ltd (ROCO:4157) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't TaiGen Biopharmaceuticals Holdings Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. TaiGen Biopharmaceuticals Holdings Ltd has returned capital to shareholders via buybacks at a rate of 0.2% over the past 3 years.

What are dividend-paying alternatives to TaiGen Biopharmaceuticals Holdings Ltd?

For dividend-paying alternatives in TaiGen Biopharmaceuticals Holdings Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.